GE HealthCare at RSNA 2024
GE HealthCare has entered a research collaboration with Erasmus MC University Medical Center Rotterdam to evaluate its developing total body PET/CT technology, with the aim of enhancing molecular imaging and advancing theranostic applications in cancer care.
The agreement will see researchers at the Netherlands-based academic hospital assess the imaging system’s ability to improve disease detection, streamline workflows, and support personalized treatment planning. The technology, which features a 128 cm axial field of view, is designed to offer high sensitivity for ultralow-dose scans and fast acquisitions, and to support dynamic imaging across multiple organs.
“Our goal is to scan more patients, faster and with dramatically lower radiation dose,” said professor Dr. Aad van der Lugt, chair of the department of radiology and nuclear medicine at Erasmus MC. “At the same time, these innovations open the door to groundbreaking research that brings us closer to truly personalized care and treatment across the Netherlands and beyond.”
Ad Statistics
Times Displayed: 174657
Times Visited: 8847
Erasmus MC has a long history in theranostics and was among the first institutions to bring targeted radiopharmaceutical therapies into clinical practice. It continues to play a key role in radiotracer development, with ongoing research into novel isotopes like zirconium (Zr) and copper (Cu).
The collaboration is part of a broader initiative to prepare for what Erik Verburg, professor of translational imaging at Erasmus MC, described as “the molecular imaging department of 2035.” Verburg said the total body PET/CT platform may expand research capabilities while accommodating rising clinical demand.
GE HealthCare’s system is intended to support both clinical and research environments. The company says it is integrating deep learning tools to optimize workflows and enhance diagnostic precision. Equipment already in use at Erasmus MC includes GE HealthCare’s Omni Legend PET/CT, StarGuide SPECT/CT, and SIGNA PET/MR systems.
The partnership also aligns with Thera4Care, a European initiative aimed at expanding access to theranostics by strengthening diagnostic infrastructure and multimodal care delivery.
link
